Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 5:57 pm Purchase |
2025-04-04 | 13G | Aura Biosciences, Inc. AURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,057,319 6.100% |
3,057,319 (New Position) |
Filing History |
| 2025-02-14 11:56 am Sale |
2024-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 4,080,605 8.170% |
-1,722,077 (-29.68%) |
Filing History |
| 2025-01-03 7:20 pm Unchanged |
2024-12-24 | 13G | Aura Biosciences, Inc. AURA |
Long Focus Capital Management LLC | 2,507,774 5.000% |
0 (Unchanged) |
Filing History |
| 2025-01-03 5:03 pm Purchase |
2024-12-24 | 13G | Aura Biosciences, Inc. AURA |
Long Focus Capital Management LLC | 2,507,774 5.700% |
2,507,774 (New Position) |
Filing History |
| 2024-11-14 5:50 pm Sale |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
Lundbeckfond Invest A/S | 1,750,108 3.500% |
-267,544 (-13.26%) |
Filing History |
| 2024-11-14 4:18 pm Sale |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 32,626 0.100% |
-3,598,868 (-99.10%) |
Filing History |
| 2024-11-12 09:32 am Purchase |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
Adage Capital Management L.P. | 4,881,125 9.840% |
4,881,125 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
BLACKROCK INC BLK |
3,160,414 6.400% |
0 (Unchanged) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
BLACKROCK INC BLK |
3,160,414 6.400% |
3,160,414 (New Position) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 3,631,494 7.400% |
894,441 (+32.68%) |
Filing History |
| 2024-02-07 07:54 am Purchase |
2023-12-31 | 13G | Aura Biosciences, Inc. AURA |
ADAGE CAPITAL PARTNERS GP LLC | 4,225,000 8.610% |
2,092,261 (+98.10%) |
Filing History |
| 2023-12-11 5:14 pm Purchase |
2023-11-30 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 5,802,682 11.820% |
3,551,314 (+157.74%) |
Filing History |
| 2023-11-09 4:34 pm Purchase |
2023-11-09 | 13D | Aura Biosciences, Inc. AURA |
Matrix Capital Management Company, LP | 6,922,870 14.100% |
1,560,000 (+29.09%) |
Filing History |
| 2023-02-14 1:30 pm Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 2,251,368 6.300% |
2,251,368 (New Position) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 2,737,053 7.400% |
421,951 (+18.23%) |
Filing History |
| 2023-02-10 4:37 pm Sale |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Arix Bioscience plc | 1,508,483 4.100% |
-91,593 (-5.72%) |
Filing History |
| 2023-02-09 10:56 am Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
ADAGE CAPITAL PARTNERS GP LLC | 2,132,739 5.760% |
42,074 (+2.01%) |
Filing History |
| 2023-01-20 4:02 pm Sale |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Chiesi Ventures Inc. | 1,218,803 3.300% |
-406,268 (-25.00%) |
Filing History |
| 2022-12-15 4:40 pm Purchase |
2022-12-05 | 13G | Aura Biosciences, Inc. AURA |
ADAGE CAPITAL PARTNERS GP LLC | 2,090,665 5.650% |
2,090,665 (New Position) |
Filing History |
| 2022-12-07 4:30 pm Purchase |
2022-12-05 | 13D | Aura Biosciences, Inc. AURA |
Matrix Capital Management Company, LP | 5,362,870 14.500% |
1,250,000 (+30.39%) |
Filing History |